About Arisan Therapeutics

Arisan Therapeutics was founded in 2010 to develop therapeutics for neglected and emerging viral diseases. A number of these infectious diseases have the potential for significant impact on public health and have been classified as priority biodefense-related pathogens.

Our scientific team is comprised of biologists, virologists and medicinal chemists with extensive drug discovery and development experience. Our efforts are further supported by a host of highly experienced collaborators and through funding from the National Institute for Allergy and Infectious Disease.

Our Mission:

To identify unmet medical needs and provide appropriate solutions through development, collaboration and partnerships to benefit patients with life-threatening infectious diseases.

Collaborators

X

Creative Commons Attribution: